Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 24 ... "The advantages of autogenous fistulas over grafts and catheters for vascular access in hemodialysis are well recognized and include lower rates of all-cause mortality and infection and ...
2009 NOV 24 ... Fresh data on dialysis are presented in the report 'Hemodialysis access failure: a call to action--revisited.' According to recent research from the ...
2009 NOV 24 ... AUCa, and the total removal of a few solutes. Fifteen patients were monitored during hemodialysis using UV absorbance at the wavelength of 297 nm. All spent dialysate passed through a ...
2009 NOV 28 ... the rates of hospital admission, critical care treatment, and use of alkalinization, hemodialysis, or intubation showed no differences with bittering. Despite the appealing logic of ...
2009 NOV 24 ... the arteriovenous fistula (AVF) is the preferred form of vascular access for chronic hemodialysis." The researchers concluded: "From observational studies have established ...
2009 NOV 24 ... for 6 months, from the first successful cannulation with 2 needles-both used for the hemodialysis treatment." "patient characteristics, comorbidities, and medication. ...
2009 NOV 24 ... reasons are reviewed." Thompson and colleagues published their study in Hemodialysis International (Mysterious PTH values after parathyroidectomy in a patient on maintenance ...
2009 NOV 23 ... According to recent research published in the journal Hemodialysis International, "Volume overload is thought to be the main cause of hypertension in ...
2009 NOV 24 ... rapidly expanding presence in the central valley, and will be equipped with 24 hemodialysis stations to serve those affected with Chronic Kidney Disease (CKD). "This ...
2009 NOV 24 ... A report, 'Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes,' is newly published data in Kidney ...
2009 NOV 23 ... bloodstream infection (CRBSI) is a source of significant morbidity and mortality in hemodialysis patients." "Several strategies for CRBSI prevention have been ...
2009 NOV 23 ... prospectively," researchers in the United States report. "Seven chronic hemodialysis patients participated in this open label, prospective pilot study to evaluate the ...
2009 NOV 23 ... "Native arteriovenous fistulae (AVF) remain the vascular access of choice for hemodialysis (HD). Despite being associated with superior long-term outcomes (cf. catheter use), ...
2009 NOV 23 ... tissues. Further investigation of excimer laser assisted angioplasty in the setting of hemodialysis access intervention is needed to rigorously define its potential role," wrote A.S. ...
2009 NOV 24 ... aim of this study was to estimate oxidative stress (OS) before and after dialysis in hemodialysis (HD) patients and correlate this stress with routine biochemical parameters. Sera of ...
2009 NOV 25 ... "Secondary hyperparathyroidsm (2HPT) is a common complication in hemodialysis patients associated with morbidity and sometimes mortality. The majority of patients ...
2009 NOV 23 ... Chong and colleagues published the results of their research in Hemodialysis International (Medication changes based on echocardiography in dialysis patients....
2009 NOV 23 ... dialysis-specific factors. An impaired vasoconstrictive response to volume loss during hemodialysis has been demonstrated and increasing evidence suggests that deficiency in the hormone ...
2009 NOV 23 ... Cardiac Trial (NHCT) was the first large, randomized study of patients receiving hemodialysis to examine the outcomes of treating anemia to a target hematocrit range of 42 +/- 3% ...
